Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct:223:30-2.
doi: 10.1016/j.jviromet.2015.07.005. Epub 2015 Jul 17.

The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy

Affiliations

The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy

Anna T Salimo et al. J Virol Methods. 2015 Oct.

Abstract

Paired plasma and dried blood spots (DBS) from 232 South African HIV-infected children initiating antiretroviral therapy (ART) were genotyped for drug resistance mutations, most of who had prior exposure to ART for prevention-of-mother-to-child-transmission. Non-nucleoside reverse transcriptase inhibitor mutations were most commonly detected in both specimen types, particularly Y181C/I and K103N/S. Resistance interpretation concordance was achieved in 97% of pairs with seven children having mutations detected in DBS only. These results validate the preferential use of DBS specimens for HIVDR genotyping in this patient group.

Keywords: Children; Dried blood spots; HIV drug resistance genotyping.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of NRTI and NNRTI mutations detected in 232 DBS and plasma specimen pairs

Similar articles

Cited by

References

    1. Bertagnolio S, Parkin NT, Jordan M, Brooks J, Garcia-Lerma JG. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS reviews. 2010;12:195–208. - PubMed
    1. Department of Health. The South African Antiretroviral Treatment Guidelines. 2013.
    1. Fitzgerald F, Penazzato M, Gibb D. Development of antiretroviral resistance in children with HIV in low- and middle-income countries. The Journal of infectious diseases. 2013;207(Suppl 2):S85–92. - PMC - PubMed
    1. Goga A. Effectiveness of the National Prevention of Mother-to-Child Transmission (PMTCT) Programme in South Africa: 2011 National SAPMTCT Survey Results. 2012.
    1. Hunt GM, Coovadia A, Abrams EJ, Sherman G, Meyers T, Morris L, Kuhn L. HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine. Aids. 2011;25:1461–1469. - PMC - PubMed

Publication types